<DOC>
	<DOC>NCT02544659</DOC>
	<brief_summary>This study is designed to evaluate long term efficacy of intravenous bisphosphonates for bone marrow edema in patients with SAPHO syndrome.</brief_summary>
	<brief_title>Efficacy of Bisphosphonates in Patients With Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO) Syndrome</brief_title>
	<detailed_description>The study will evaluate the long term efficacy at 3 days, 3 and 6 months after pamidronate disodium administered. Patients will be administered pamidronate disodium 1 mg/kg, IV, QD, for 3 days, and every 3 months (up to month 6).</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Acquired Hyperostosis Syndrome</mesh_term>
	<mesh_term>Pamidronate</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<criteria>1. Male and female patients between the ages of 18 and 70 years 2. Only 1 of the 4 inclusion criteria is sufficient to arrive at a diagnosis of SAPHO syndromeï¼š Osteoarticular manifestations of acne conglobata, acne fulminans, or hidradenitis suppurativa Osteoarticular manifestations of PPP Hyperostosis (of the anterior chest wall, limbs or spine) with or without dermatosis CRMO involving the axial or peripheral skeleton with or without dermatosis Palmoplantar pustulosis(PPP); chronic recurrent multifocal osteomyelitis(CRMO) 3. MRI shows bone marrow edema in affected site in patients 4. Blood serum of patients show the normal white blood cell count, liver and renal function 5. Patients who like to be followed up for 1 years 6. Other protocol defined inclusion criteria may apply 1. Women in pregnancy or lactation. 2. Septic osteomyelitis 3. Infectious chest wall arthritis 4. Infections PPP 5. Palmoplantar keratodermia 6. DISH except for fortuitous association 7. Osteoarticular manifestations of retinoid therapy 8. Other protocol defined exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Treatment</keyword>
	<keyword>Bisphosphonates</keyword>
	<keyword>Response rate</keyword>
</DOC>